Dr. Smitha Gubbi, MD

NPI: 1275620650
Total Payments
$8,058
2024 Payments
$1,758
Companies
47
Transactions
553
Medicare Patients
4,445
Medicare Billing
$753,527

Payment Breakdown by Category

Food & Beverage$8,017 (99.5%)
Education$41.18 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,017 548 99.5%
Education $41.18 5 0.5%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,261 95 $0 (2024)
AstraZeneca Pharmaceuticals LP $773.33 55 $0 (2024)
Janssen Pharmaceuticals, Inc $590.38 47 $0 (2024)
SANOFI-AVENTIS U.S. LLC $472.89 30 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $360.50 24 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $345.72 29 $0 (2024)
Allergan, Inc. $324.78 26 $0 (2020)
Merck Sharp & Dohme LLC $319.35 25 $0 (2024)
Otsuka America Pharmaceutical, Inc. $313.50 17 $0 (2024)
Lilly USA, LLC $288.81 19 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,758 102 Novo Nordisk Inc ($304.46)
2023 $1,136 74 Novo Nordisk Inc ($144.19)
2022 $615.22 39 Novo Nordisk Inc ($70.79)
2020 $151.38 11 Boehringer Ingelheim Pharmaceuticals, Inc. ($27.13)
2019 $1,346 107 Novo Nordisk Inc ($331.27)
2018 $1,305 102 Novo Nordisk Inc ($219.39)
2017 $1,747 118 SANOFI-AVENTIS U.S. LLC ($223.55)

All Payment Transactions

553 individual payment records from CMS Open Payments — Page 1 of 23

Date Company Product Nature Form Amount Type
12/20/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.17 General
Category: Cardiovascular and Metabolism
12/17/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $34.63 General
Category: Oncology
12/04/2024 PFIZER INC. PAXLOVID (Drug) Food and Beverage In-kind items and services $15.44 General
Category: INFECTIOUS DISEASES
12/03/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.00 General
Category: Respiratory
11/27/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $20.89 General
Category: Cardio-renal
11/26/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $16.17 General
Category: VACCINES
11/20/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $13.13 General
Category: Diabetes
11/19/2024 Merck Sharp & Dohme LLC LAGEVRIO (Drug) Food and Beverage In-kind items and services $17.08 General
Category: INFECTIOUS DISEASE
11/07/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $15.56 General
Category: Diabetes
10/31/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $13.34 General
Category: Diabetes
10/23/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.51 General
Category: Respiratory
10/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $7.53 General
Category: Gastroenterology
10/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $4.90 General
Category: Gastroenterology
10/22/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.27 General
Category: PSYCHIATRY
10/17/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $22.93 General
Category: Biological
10/16/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $23.81 General
Category: Cardio-renal
10/15/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $16.44 General
10/14/2024 MITSUBISHI TANABE PHARMA AMERICA, INC. RADICAVA (Drug), RADICAVA ORS Food and Beverage In-kind items and services $15.50 General
Category: AMYOTROPHIC LATERAL SCLEROSIS
10/09/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $14.30 General
Category: Diabetes
10/09/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $13.12 General
Category: Respiratory
10/07/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $19.06 General
Category: Neuroscience
10/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.50 General
Category: Gastroenterology
09/27/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.09 General
Category: Cardiovascular and Metabolism
09/26/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $14.09 General
09/24/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $33.10 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 1,115 2,001 $613,072 $183,125
2022 18 1,188 2,373 $711,418 $202,439
2021 20 977 2,299 $681,544 $193,055
2020 21 1,165 2,335 $657,743 $174,908
Total Patients
4,445
Total Services
9,008
Medicare Billing
$753,527
Procedure Codes
76

All Medicare Procedures & Services

76 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 294 739 $268,257 $72,733 27.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 263 263 $104,411 $37,399 35.8%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 41 263 $60,753 $16,921 27.9%
99496 Transitional care management services for problem of high complexity Office 2023 36 44 $34,628 $10,592 30.6%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 106 106 $9,858 $8,036 81.5%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Office 2023 25 146 $33,726 $7,940 23.5%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 84 112 $28,560 $7,793 27.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 62 114 $28,158 $7,290 25.9%
G0008 Administration of influenza virus vaccine Office 2023 114 114 $3,990 $3,873 97.1%
99305 Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes Facility 2023 25 31 $13,392 $3,422 25.6%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 16 16 $8,912 $2,710 30.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 20 20 $11,020 $2,630 23.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 11 14 $6,286 $1,557 24.8%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 18 19 $1,121 $231.48 20.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 279 688 $249,744 $67,402 27.0%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 97 576 $133,056 $34,108 25.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 208 208 $82,576 $30,267 36.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 106 198 $48,906 $13,755 28.1%
99496 Transitional care management services for problem of high complexity Office 2022 33 42 $33,054 $10,476 31.7%
99308 Follow-up nursing facility visit per day, typically 15 minutes Office 2022 31 192 $44,352 $10,060 22.7%
99305 Initial nursing facility visit per day, typically 35 minutes Facility 2022 51 57 $24,624 $6,366 25.9%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 56 75 $19,125 $5,000 26.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 36 36 $19,836 $4,128 20.8%
90662 Influenza vaccine split virus, preservative free Office 2022 56 56 $4,144 $3,838 92.6%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 16 16 $9,280 $2,962 31.9%

About Dr. Smitha Gubbi, MD

Dr. Smitha Gubbi, MD is a Family Medicine healthcare provider based in Bridgewater, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275620650.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Smitha Gubbi, MD has received a total of $8,058 in payments from pharmaceutical and medical device companies, with $1,758 received in 2024. These payments were reported across 553 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,017).

As a Medicare-enrolled provider, Gubbi has provided services to 4,445 Medicare beneficiaries, totaling 9,008 services with total Medicare billing of $753,527. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Bridgewater, NJ
  • Active Since 10/06/2006
  • Last Updated 10/07/2016
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1275620650

Products in Payments

  • FARXIGA (Drug) $481.46
  • Ozempic (Drug) $383.91
  • REXULTI (Drug) $338.06
  • XIFAXAN (Drug) $331.65
  • XARELTO (Drug) $325.85
  • Cologuard Collection Kit (Device) $247.77
  • BREZTRI (Drug) $191.75
  • Rybelsus (Drug) $191.53
  • TOUJEO (Drug) $182.30
  • JARDIANCE (Drug) $173.04
  • JANUVIA (Drug) $168.57
  • SOLIQUA (Drug) $162.13
  • Tresiba (Drug) $160.97
  • ENTRESTO (Drug) $156.56
  • Victoza (Drug) $151.60
  • INVOKANA (Drug) $149.96
  • Livalo (Drug) $147.13
  • TRADJENTA (Drug) $132.92
  • Veozah (Drug) $126.33
  • Prolia (Biological) $123.72

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Bridgewater